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Abstract
The DEAD box helicase DDX3 assembles IPS-1 (also called Cardif, MAVS, or VISA) in non-infected human cells where minimal
amounts of the RIG-I-like receptor (RLR) protein are expressed. DDX3 C-terminal regions directly bind the IPS-1 CARD-like
domain as well as the N-terminal hepatitis C virus (HCV) core protein. DDX3 physically binds viral RNA to form IPS-1-
containing spots, that are visible by confocal microscopy. HCV polyU/UC induced IPS-1-mediated interferon (IFN)-beta
promoter activation, which was augmented by co-transfected DDX3. DDX3 spots localized near the lipid droplets (LDs)
where HCV particles were generated. Here, we report that HCV core protein interferes with DDX3-enhanced IPS-1 signaling
in HEK293 cells and in hepatocyte Oc cells. Unlike the DEAD box helicases RIG-I and MDA5, DDX3 was constitutively
expressed and colocalized with IPS-1 around mitochondria. In hepatocytes (O cells) with the HCV replicon, however, DDX3/
IPS-1-enhanced IFN-beta-induction was largely abrogated even when DDX3 was co-expressed. DDX3 spots barely merged
with IPS-1, and partly assembled in the HCV core protein located near the LD in O cells, though in some O cells IPS-1 was
diminished or disseminated apart from mitochondria. Expression of DDX3 in replicon-negative or core-less replicon-positive
cells failed to cause complex formation or LD association. HCV core protein and DDX3 partially colocalized only in replicon-
expressing cells. Since the HCV core protein has been reported to promote HCV replication through binding to DDX3, the
core protein appears to switch DDX3 from an IFN-inducing mode to an HCV-replication mode. The results enable us to
conclude that HCV infection is promoted by modulating the dual function of DDX3.
Citation: Oshiumi H, Ikeda M, Matsumoto M, Watanabe A, Takeuchi O, et al. (2010) Hepatitis C Virus Core Protein Abrogates the DDX3 Function That Enhances
IPS-1-Mediated IFN–Beta Induction. PLoS ONE 5(12): e14258. doi:10.1371/journal.pone.0014258
Editor: Jo ¨rn Coers, Duke University Medical Center, United States of America
Received May 28, 2010; Accepted November 16, 2010; Published December 8, 2010
Copyright:  2010 Oshiumi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT, Sapporo
Biocluster ‘‘Bio-S’’, the Knowledge Cluster Initiative of the MEXT, Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced
Research) and the Ministry of Health, Labor, and Welfare of Japan, Mochida Foundation, Yakult Foundation, NorthTec Foundation and Waxman Foundation. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: seya-tu@pop.med.hokudai.ac.jp
Introduction
The retinoic acid inducible gene-I (RIG-I) and the melanoma
differentiation-associated gene 5 (MDA5) encode cytoplasmic
RNA helicases [1–3] that signal the presence of viral RNA
through the adaptor, IPS-1/Mitochondrial antiviral signaling
protein (MAVS)/Caspase recruitment domain (CARD) adaptor
inducing interferon (IFN)-beta (Cardif)/Virus-induced signaling
adaptor (VISA) to produce IFN-beta [4–7]. IPS-1 is localized to
the mitochondrial outer membrane through its C-terminus [6].
Increasing evidence suggests that the DEAD-box RNA helicase
DDX3, which is on the X chromosome, participates in the
regulation of type I IFN induction by the RIG-I pathway.
DDX3 acts on the IFN-inducing pathway by a complex
mechanism. Early studies reported that DDX3 up-regulates IFN-
beta induction by interacting with IKKepsilon [8] or TBK1 [9] in
a kinase complex. Both TBK1 and IKKepsilon are IRF-3-
activating kinases with NF-kappaB- and IFN-inducible properties.
DDX3 has been proposed to bind IKKepsilon, and IKKepsilon is
generated after NF-kappaB activation [10]. Yeast two-hybrid
studies demonstrated that DDX3 binds IPS-1, and both are
constitutively present prior to infection (Fig. 1). Ultimately, DDX3
forms a complex with the DEAD-box RNA helicases RIG-I and
MDA5 [11], which are present at only low amounts in resting
cells, and are up-regulated during virus infection. Previously we
used gene silencing and disruption, to show that the main function
of DDX3 is to interact with viral RNA and enhance RIG-I
signaling upstream of NAP1/TBK1/IKKepsilon [11]. Hence,
DDX3 is involved in multiple pathways of RNA sensing and
signaling during viral infection.
DDX3 resides in both the nucleus and the cytoplasm [12], and
has been implicated in a variety of processes in gene expression
regulation, including transcription, splicing, mRNA export, and
translation [13]. A recent report suggested that the N-terminus of
hepatitis C virus (HCV) core protein binds the C-terminus of
DDX3 (Fig. S1) [14,15], and this interaction is required for HCV
replication [16]. Although DDX3 promotes efficient HCV
infection by accelerating HCV RNA replication, the processes
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[15]. HCV seems to co-opt DDX3, and require DDX3 for
replication. In addition, the association between DDX3 and core
protein implicates DDX3 in HCV-related hepatocellular carcino-
ma progression [17]. Therefore, DDX3 could be a novel target for
the development of drugs against HCV [18].
A number of reports have demonstrated the formation of the
DDX3-core protein complex in the cytoplasm, but the functional
relevance of DDX3-core protein interaction is not known. In this
report, we show evidence that the HCV core protein participates
in suppression of DDX3-augmented IPS-1 signaling for IFN-b
induction. Several possible functions of DDX3 are discussed,
focusing on its core protein association and IPS-1-regulatory
properties.
Materials and Methods
Cell culture and reagents
HEK293 cells and HEK293FT cells were maintained in
Dulbecco’s Modified Eagle’s low or high glucose medium
(Invitrogen, Carlsbad, CA) supplemented with 10% heat-inacti-
vated FCS (Invitrogen) and antibiotics. Huh7.5 cells were
maintained in MEM (Nissui, Tokyo, Japan) supplemented with
10% heat-inactivated FCS. Hepatocyte sublines with HCV
replicon (O cells) and without replicon (Oc cells) were established
as described previously [19]. O cells with core-less subgenomic
replicon (sO cells) were also generated in Dr. Kato’s laboratory
[16,19]. RIG-I 2/2 mouse embryonic fibroblasts (MEF) were
gifts from Drs. Takeuchi and Akira [1]. Anti-FLAG M2
monoclonal Ab and anti-HA polyclonal Ab were purchased from
Sigma. A mitochondria marker (Mitotracker) and Alexa FluorH-
conjugated secondary antibodies were purchased from Molecular
probe. Anti-HCV core mAb (C7-50) [20] and anti-human DDX3
pAb were from Affinity BioReagents, Inc and Abcam, Cambridge
MA, respectively.
Plasmids
DDX3 cDNA encoding the entire ORF was cloned into pCR-
blunt vector using primers, DDX3N F-Xh (CTC GAG CCA CCA
TGA GTC ATG TGG CAG TGG AA) and DDX3C R-Ba (GGA
TCC GTT ACC CCA CCA GTC AAC CCC) from human lung
cDNA library. To make an expression plasmid, HA tag was fused at
the C-terminal end of the full length DDX3 (pEF-BOS DDX3-HA).
pEF-BOS DDX3 (1-224aa) vector was made by using primers,
Figure 1. DDX3 is a RNA-binding protein. (A) DDX3 is a polyU- and polyI:C-binding protein. Mass spectrometry analyses indicated that DDX3
binds polyI:C- and polyU-Sepharose, although PKR binds polyI:C but not polyU. The rough data from MASCOT and one representative of six trials are
shown. (B) DDX3 binds dsRNA, RIG-I and HCV core protein. Expression vectors for Flag-tagged RIG-I and HA-tagged DDX3 were transfected into
HEK293 cells using lipofectamine 2000. Twenty-four hours after the transfection, extract from transfected cells were mixed with biotin-conjugated
dsRNA. RNA-protein complex were recovered by pull-down assay using streptavidin-Sepharose. The protein within the pull-down fraction was
analyzed by western blotting. The results are representative of two independent experiments.
doi:10.1371/journal.pone.0014258.g001
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CAA GTC TCT TTT C). pEF-BOS DDX3-HA (225-662) was
made by using primers, DDX3D2-3 (CTC GAG CCA CCA TGC
AAA CAG GGT CTG GAA AAA C) and DDX3C R-Ba. To make
pEF-BOS DDX3-HA (225-484) and pEF-BOS DDX3-HA (485-
663), the primers, DDX3D2 R-Ba (GGA TCC AAG GGC CTC
TTC TCT ATC CCT C) and DDX3D3 F-Xh (CTC GAG CCA
CCA TGC ACC AGT TCC GCT CAG GAA AAA G) were used,
respectively. HCVcore expressing plasmids, pcDNA3.1 HCVO core
or JFH1 core, were previously reported by N. Kato (Okayama
University Japan) [16]. Another 1b genotype of the core was cloned
from a HCV patient in Osaka Medical Center (Osaka) according to
the recommendation of the Ethical Committee in Osaka. We
obtained written informed consent from each patient for research use
of their samples. Reporter and internal control plasmids for reporter
gene assay are previously described [21,22].
Figure 2. DDX3 is a positive regulator of IPS-1-mediated IFN promoter activation. (A) IFN-b induction by polyU/UC is augmented by DDX3.
IPS-1 (100 ng), DDX3 (100 ng) and p125luc reporter (100 ng) plasmids were transfected into HEK293 cells in 24-well plates with or without the HCV 39
UTR poly U/UC region (PU/UC) RNA (0, 25 or 50 ng/well), synthesized in vitro by T7 RNA polymerase. HCV RNA-enhancing activation of IFN-beta
promoter was assessed by reporter assay in the presence or absence of the DDX3-IPS-1 complex. (B) RIG-I is essential for the DDX3/IPS-1-mediated
IFN-promoter activation. MEF from wild-type and RIG-I 2/2 mice were transfected with plasmids of IPS-1, DDX3 and p125luc as in panel A, and
stimulated with polyU/UC (0, 25 or 50 ng/well). Reporter activity was determined as in panel A. (C) Knockdown of DDX3. Negative control or DDX3
targeting siRNA (20 pmol), DDX3 si-1, was transfected into HEK293 cells, and after 48 hrs, expression of endogenous DDX3 mRNA was examined by
real-time RT-PCR. DDX3 si-1-mediated down-regulation of the DDX3 protein was also confirmed by Western blotting (data not shown). (D) DDX3
enhances RIG-I-mediated IFN-beta promoter activation induced by polyU/UC. DDX3 si-1 or control siRNA was transfected into HEK293 cells with
reporter plasmids (100 ng). After 48 hrs, cells were stimulated with polyU/UC (5,50 ng/ml) with lipofectamin 2000 reagent for 6 hrs, and activation
of the reporter p125luc was measured. The results are representative of at least two independent experiments, each performed in triplicate.
doi:10.1371/journal.pone.0014258.g002
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The HCV genotype 1b polyU/UC RNA (from 9421 to 9480,
Accession number: EU867431) [23] was synthesized by T7 RNA
polymerase in vitro. The template dsDNA sequences were;
Forward: TAA TAC GAC TCA CTA TAG GGT TCC CTT
TTT TTT TTT CTT TTT TTT TTT TTT TTT TTT TTT
TTT TTT CTC CTT TTT TTT TC, Reverse: GAA AAA AAA
AGG AGA AAA AAA AAA AAA AAA AAA AAA AAA AAA
AGA AAA AAA AAA AGG GAA CCC TAT AGT GAG TCG
TAT TA. The synthesized RNA was purified by TRIZOL reagent
(Invitrogen). cDNA of HCV 39 UTR region was amplified from
total RNA of O cells using primers HCV-F1 and HCV-R1, and
then cloned into pGEM-T easy vector. The primer set sequences
were HCV-F1: CTC CAG GTG AGA TCA ATA GG and HCV-
R1: CGT GAC TAG GGC TAA GAT GG. RNA was
synthesized using T7 and SP6 RNA polymerases. Template
DNA was digested by DNase I, and RNA was purified using
TRIZOL (Invitrogen) according to manufacturer’s instructions.
RNAi
Knockdown of DDX3 was carried out using siRNA, DDX3
siRNA-1: 59-GAU UCG UAG AAU AGU CGA ACA-39, siRNA-
2: 59-GGA GUG AUU ACG AUG GCA UUG-39, siRNA-3: 59-
GCC UCA GAU UCG UAG AAU AGU-39 and control siRNA:
59-GGG AAG AUC GGG UUA GAC UUC-39. 20 pmol of each
siRNA was transfected into HEK293 cells in 24-well plate with
Lipofectamin 2000 according to manufacture’s protocol. Knock-
down of DDX3 was confirmed 48 hrs after siRNA transfection.
Experiments were repeated twice for confirmation of the results.
Reporter assay
HEK293 cells (4610
4 cells/well) cultured in 24-well plates were
transfected with the expression vectors for IPS-1, DDX3 or empty
vector together with the reporter plasmid (100 ng/well) and an
internal control vector, phRL-TK (Promega) (2.5 ng/well) using
FuGENE (Roche) as described previously [23]. The p-125 luc
reporter containing the human IFN-beta promoter region (2125
to +19) was provided by Dr. T. Taniguchi (University of Tokyo,
Tokyo, Japan). The total amount of DNA (500 ng/well) was kept
constant by adding empty vector. After 24 hrs, cells were lysed in
lysis buffer (Promega), and the Firefly and Renella luciferase
activities were determined using a dual-luciferase reporter assay
kit (Promega). The Firefly luciferase activity was normalized by
Renella luciferase activity and is expressed as the fold stimulation
relative to the activity in vector-transfected cells. Experiments were
performed three times in duplicate (otherwise indicated in the
legends).
PolyI:C or polyU/UC stimulation
PolyI:C was purchased from GE Healthcare company, and
solved in milliQ water. For polyI:C treatment, polyI:C was mixed
with DEAE-dextran (0.5 mg/ml) (Sigma) in the culture medium,
and the cell culture supernatant was replaced with the medium
containing polyI:C and DEAE-dextran. Using DEAE-dextran,
polyI:C is incorporated into the cytoplasm to activate RIG-I/
MDA5.
HCV 39 UTR poly U/UC region (PU/UC) RNA (0,50 ng/
well), which is synthesized in vitro by T7 RNA polymerase,
transfected into HEK293 cells in 24-well plate by lipofectamin
2000 (Invitrogen) with other plasmids. Cells were allowed to stand
for 24,48 hrs and HCV RNA-enhancing activation of IFN-beta
promoter was assessed by reporter assay.
Immunoprecipitation (i.p.)
HEK293FT cells were transfected in a 6-well plate with
plasmids encoding DDX3, IPS-1, RIG-I or MDA5 as indicated
in the figures. 24 hrs after tranfection, the total cell lysate was
prepared by lysis buffer (20 mM Tris-HCl [pH 7.5] containing
125 mM NaCl, 1 mM EDTA, 10% Glycerol, 1% NP-40, 30 mM
NaF, 5 mM Na3Vo4, 20 mM IAA and 2 mM PMSF), and the
protein was immunoprecipitated with anti-HA polyclonal (SIG-
MA) or anti-FLAG M2 monoclonal Ab (SIGMA). The precipi-
tated samples were resolved on SDS-PAGE, blotted onto a
nitrocellulose sheet and stained with anti-HA (HA1.1) monoclonal
(SIGMA), anti-HA polyclonal or anti-FLAG M2 monoclonal Ab.
Pull-down assay
The pull-down assay was performed according to the method
described in Saito T et al. [24]. Briefly, the RNA used for the assay
was purchased from JBioS, Co. Ltd (Saitama, Japan). The RNA
sequences are (sense strand) AAA CUG AAA GGG AGA AGU
GAA AGU G, (antisense strand)CAC UUU CAC UUC UCC
CUU UCA GUU U. The biotin is conjugated at U residue at the
39 end of antisence strand (underlined). Biotinylated double-
stranded (ds)RNA were incubated for 1 hr at 25uC with 10 mgo f
protein from the cytoplasmic fraction of cells that were transfected
with Flag-tagged RIG-I and HA-tagged DDX3 expressing vectors.
The mixture was transferred into 400 ml of lysis buffer containing
25 ml of streptavidine Sepharose beads, rocked at 4uC for 2 h,
collected by centrifugation, washed three times, resuspended in
SDS sample buffer.
Proteome analysis of RNA-binding proteins
RNA-binding proteins were identified by affinity chromatogra-
phy and Mass spectrometry. Briefly, cell lysate was prepared from
human HEK293 or Raji cells as will be described elsewhere
(Watanabe and Matsumoto, manuscript submitted for publica-
tion). The lysate was first applied to polyU-Sepharose and then the
pass-through fraction was applied to PolyI:C-Sepharose. The
eluted proteins were analyzed on Mass spectrometry using the
MASCOT software.
Confocal analysis
HCV replicon-positive (O) or –negative (Oc) cells were plated
onto cover glass in a 24-well plate. In the following day, cells were
transfected with indicated plasmids using Fugene HD (Roch). The
Figure 3. The HCV replicon suppresses IPS-1/DDX3-mediated augmentation of IFN promoter activation. (A,B) O cells with the HCV
replicon fail to activate an IFN-b reporter in response to IPS-1/DDX3. O cells contain the full-length HCV replicon, and Oc cells do not [16]. O cells (A)
or Oc cells (B) were transfected with IPS-1, DDX3 or p125luc reporter plasmids. At timed intervals (24 hrs), reporter activity was determined as in Fig.2 .
(C,D) The HCV replicon suppresses IFN-promoter activation by polyU/UC. O cells and Oc cells expressing IPS-1 and DDX3 were stimulated with polyU/
UC. At 48 hrs, reporter activity was determined as in panel A. (E) DDX3 is required for enhanced activation of IFN-beta promoter by O cell HCV 39UTR.
HCV 39 UTR cDNA was amplified by RT-PCR from RNA extracted from O cells containing full-length HCV replicon. The HCV 39 UTR RNA was
synthesized in vitro using T7 RNA polymerase. DDX3 siRNA or control siRNA was transfected into HEK293 cells with the p125luc reporter. After 24 hrs,
cells were transfected with HCV RNA, and incubated for 24 hrs. The IFN-beta promoter activation was assessed by luciferase reporter assay. One
representative of at least three independent experiments, each performed in triplicate, is shown.
doi:10.1371/journal.pone.0014258.g003
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24 hrs, cells were fixed with 3% of paraformaldehyde in PBS for
30 minutes, and then permeabilized with PBS containing 0.2% of
Triton X-100 for 15 min. Permeabilized cells were blocked with
PBS containing 1% BSA, and were labeled with anti-Flag M2
mAb (Sigma) or anti-HA pAb (Sigma) in 1% BSA/PBS for 1 hr at
room temperature [25]. In some cases, endogenous proteins were
directly stained with anti-core (C7-50) mAb (Affinity BioReagents,
Inc) or anti-DDX3 pAbs (Abcam, Cambridge MA). The cells were
then washed with 1% BSA/PBS and treated for 30 min at room
temperature with Alexa-conjugated antibodies (Molecular Probes).
Thereafter, micro-cover glass was mounted onto slide glass using
PBS containing 2.3% DABCO and 50% of glycerol. The stained
cells were visualized at 660 magnification under a FLUOVIEW
(Olympus, Tokyo, Japan).
Results
DDX3 binds RNA species
We have performed proteome analyses of RNA-binding
fractions in human dendritic cell lysate eluted from polyU and
polyI:C Sepharose. 127 cytoplasmic proteins were reproducibly
identified as polyI:C-binding proteins (Watanabe and Matsumoto,
unpublished data). Four of them are DEAD/H box helicases. In
this setting, we found DDX3 is a RNA-binding protein (Fig. 1A).
DDX3 in cell lysate bound both polyU and polyI:C, while the
control PKR bound only to polyI:C.
Using biotinylayed dsRNA, RNA-binding properties of DDX3
and RIG-I were tested by pull-down assay. DDX3 or RIG-I
protein was co-precipitated with dsRNA in HEK293 cells
expressing either alone of DDX3 or RIG-I (Fig. 1B). Strikingly,
higher amounts of DDX3 and RIG-I were precipitated with
dsRNA in cells expressing both proteins (Fig. 1B). This, taken
together with previous results [11,14,16], indicates that DDX3
assembles in some RNA, RIG-I, IPS-1 and HCV core protein in
its C-terminal domain (Fig. S1).
PolyU/UC but not replicon enhances IFN-b induction via
IPS-1/DDX3
A polyU/UC sequence is present in the 39-region of the HCV
genome, and serves as a ligand for RIG-I in IPS-1 pathway
activation [23]. We produced the polyU/UC RNA and tested its
IFN-beta-inducing activity in the presence or absence of DDX3
and IPS-1 (Fig. 2A). HCV polyU/UC promoted IPS-1-mediated
IFN-beta induction, and this was further enhanced by forced
expression of DDX3/IPS-1 (Fig. 2A). Similar results were
obtained with wild-type mouse embryonic fibroblasts (MEF)
(Fig. 2B). We also investigated whether DDX3 enhanced IPS-1-
mediated IFN-b promoter activation in a RIG-I 2/2 MEF
background (Fig. 2B). In IPS-1/DDX3-expressing MEF cells,
polyU/UC IFN-induction was almost totally abrogated by the lack
of RIG-I, suggesting that the trace RIG-I protein in the IPS-1
complex is required for DDX3 enhancement of the polyU/UC-
mediated IFN response.
DDX3 mRNA (Fig. 2C) and protein [11] were depleted in
HEK293 cells by gene silencing with si-1 siRNA, so this was used
for DDX3 loss-of-function analysis. Control or DDX3-silinced
cells were transfected with increasing amounts of polyU/UC and
IFN-beta promoter activation was determined by luciferase assay.
DDX3 loss-of-function resulted in a decrease of promoter
activation by intrinsic polyU/UC (Fig. 2D). The result was
confirmed with cells over-expressing RIG-I and exogenous
polyI:C stimulation. HEK293 cells were transfected with a
plasmid for the expression of RIG-I and stimulated with polyI:C,
an activator of the IPS-1 pathway (Fig. S2A). IFN-beta reporter
activation was suppressed in si-1-treated cells that expressed RIG-
I, since polyI:C lots often contain short size duplexes that can
activate RIG-I [26]. In addition, DDX3 augmented the IFN-beta
response in cells expressing MDA5/IPS-1 (Fig. S2B). Thus,
DDX3 was also crucial for IPS-1-mediated IFN-beta promoter
activation.
We next determined whether the HCV replicon triggers IPS-1/
DDX3 IFN promoter activation, using human hepatocyte lines
with the HCV replicon (O cells) or without it (Oc cells). In O cells
with the HCV replicon, IPS-1/DDX3 expression showed minimal
enhancement of IFN-beta promoter activation (Fig. 3A), while in
control Oc cells with no replicon, DDX3 facilitated IFN-beta
promoter activation (Fig. 3B). Similarily, an augmented IFN
promoter response to polyU/UC was observed in control Oc cells,
but not in O cells (Figs. 3C and 3D). HCV RNA was prepared
from O cells, and its ability to activate the IFN-beta reporter was
tested in HEK293 cells (Fig. 3E). The HCV RNA of O cells had a
high potency to induce reporter activation, and this activity was
largely abrogated by si-1 siRNA treatment. Therefore, DDX3
augments IPS-1-mediated IFN-beta promoter activation in
hepatocyte O cells, and HCV RNA, presumably the 39UTR,
participates in this induction. However, no IFN-beta reporter
activation was detected in O cells which harbor HCV replicon.
Therefore, an unidentified viral factor appeared to participate in
suppressing virus RNA-mediated IFN-beta induction, which
occurred in O cells overexpressing DDX3/IPS-1.
HCV core protein inhibits IPS-1 signaling through DDX3
What HCV proteins participate in IFN-beta induction was
tested in a pilot study using protein expression analysis. We found
that expression of HCV core protein as well as NS3/4A led to
suppression of IFN-beta reporter activity in Oc cells (data not
shown). The HCV core protein physically binds DDX3 [14,16],
and co-localizes with DDX3 in the cytoplasm of HeLa cells
transfected with HCV core protein [14]. Furthermore, we showed
that DDX3 binds IPS-1, which resides on the mitochondrial outer
membrane, and assembles into RNA-sensing receptors. Since
some populations of the HCV core protein localize on the
mitochondrial outer membrane [27], we tested if HCV core
Figure 4. HCV core protein inhibits DDX3 promotion of IPS-1-mediated IFN-beta induction. (A) Expression plasmids for IPS-1 (100 ng),
DDX3 (200 ng) and/or HCVO core (50 or 100 ng) were transfected into HEK293 cells in 24-well plates with reporter plasmids, and reporter activity was
examined. (B) Expression plasmids for IPS-1 (100 ng), DDX3 (100 ng), and/or HCVO or JFH1 core (10, 25, 50 or 100 ng) were transfected into HEK293
cells, and reporter gene expression was analyzed. (C) IPS-1-, IKKepsilon- or NAP1-expressing plasmids were transfected into HEK293 cells with HCV
JFH1 core-expressing plasmids (25 or 100 ng), for reporter gene analysis. (D) Plasmids for expression of FLAG-tagged IPS-1 (400 ng), HA-tagged DDX3
partial fragment (400 ng) and HCVO or JFH1 core (400 ng) were transfected into HEK293FT cells. 24 hrs later cells were lyzed and the lysate was
incubated with anti-HA Ab for immunoprecipitation. The DDX3 (224-662)-bound IPS-1 was blotted onto a sheet and probed with anti-Flag Ab. Whole
cell lysate was also stained with anti-tag Abs. (E) IPS-1 (100 ng), DDX3 (100 ng), JFH1 core (50 ng) and/or p125 luc reporter (100 ng) plasmids were
transfected with HEK293 cells, with HCV 39UTR poly-U/UC (PU/UC) RNA (25 ng), synthesized in vitro. Cell lysates were prepared after 24 hrs, and
luciferase activities measured. One representative of at least three independent experiments is shown except for panel D, which is a representative of
two sets of the experiments.
doi:10.1371/journal.pone.0014258.g004
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for HCV core proteins, genotype 1b (HCVO) and 2a (JFH1) [16],
were co-transfected into HEK293 together with IPS-1, DDX3,
and reporter plasmids, and core protein interference with IPS-1/
DDX3-mediated IFN-beta promoter activation was examined.
We found that the core proteins of HCVO and JFH1 suppressed
IPS-1/DDX3-augmented IFN-beta-induction in a dose-depen-
dent manner (Fig. 4A and 4B). Without DDX3 transfection, core
protein had no effect on IPS-1-mediated IFN-beta promoter
activation (Fig. 4A). JFH1 core slightly more efficiently inhibited
IPS-1/DDX3-augmented IFN-beta-induction than HCVO core
(Fig. 4B).
Although some endogenous DDX3 was present in the
cytoplasm without DDX3 transfection, only IPS-1 transfection
permitted minimal induction of IFN-beta. It is notable that high
doses of the HCV JFH1 core protein was needed to inhibit the
IPS-1-mediated IFN-beta-induction signal (Fig. 4C, left panel).
Since the imaging profile of DDX3 is not always monotonous in
human cells, its distribution may be biased in the cytoplasm, which
may reason that only a high dose of HCV core involves
preoccupied DDX3 protein to inhibit the IPS-1 pathway. This is
consistent with earlier reports on an NS3-independent mechanism
to block IFN induction using HCV-infected Huh 7 cells [28].
IPS-1 transduces a RNA replication signal to result in IFN-beta
output using downstream proteins, such as NAP1 and IKKeysilon.
If the HCV core protein interferes with IPS-1 function through
DDX3, the core should not inhibit over-expressed downstream
molecules. As predicted, HCV core protein did not suppress the
IKKepsilon- or NAP1-mediated IFN-beta-inducing signal (Fig. 4C,
center and right panels). Hence, the core protein blocks the action
of endogenous DDX3 and overexpressed IPS-1 to facilitate
minimal IFN-beta promoter activation, and this IFN-beta blocking
function of core does not target IKKepsilon or NAP1 (Fig. 4C). An
upstream molecule of IKKepsilon and NAP1 is predicted to be the
target of the HCV core protein, which is in line with the fact that
the HCV core protein interacts with DDX3 [14,16].
To further confirm this model, we examined whether the HCV
core protein inhibits the physical interaction between IPS-1 and
DDX3. Full length IPS-1 and the C-terminal fragment of DDX3,
which binds to the IPS-1 CARD-like region, were transfected into
HEK293 cells, with or without the HCV core protein, and the
DDX3 fragment was immunoprecipitated. Expression of HCV
core proteins strongly inhibited interaction between the DDX3 C-
terminal fragment and IPS-1 (Fig. 4D). JFH1 core appeared to
show greater inhibition to DDX3-IPS-1 interaction than HCVO.
We then examined this IFN-beta blocking function of JFH1 core
in a similar cell condition plus polyU/UC. DDX3/IPS-1-
enhanced p125luc reporter activity in cells stimulated with
polyU/UC (Fig. 4E) was decreased in cells expressing HCV core.
The results suggest that the role of the core in HCV-infected cells
is to remove DDX3 from IPS-1, and facilitate its interaction with
HCV replication complex (Fig. S1).
PolyU/UC HCV RNA activates the IFN-beta promoter
(Fig. 2A), and this activity was inhibited by expression of the
HCV core protein (Fig. 4E). PolyI:C/RIG-I-mediated IFN-b
promoter activation was similarly suppressed by the core protein
Figure 5. Properties of a 1b-type core protein in the IPS-1
pathway. (A) A core protein derived from an HCV patient suppressed
DDX3-mediated activation of IPS-1 signaling. The 1b-type core protein
was cloned into the pCMV vector from a patient with hepatitis C. IPS-1
(100 ng), DDX3 (100 ng) and HCV core (100 ng) expression vectors
were transfected into HEK293 cells with a reporter plasmid (p125luc),
for analysis as in Figure 4. (B) The core protein reduced interaction
between full-length DDX3 and IPS-1. The plasmids encoding core
protein (400 ng), DDX3-HA (400 ng) and FLAG-IPS-1 (400 ng) were
transfected into HEK293FT cells. After 24 hrs, cell lysates were prepared
and immunoprecipitation was carried out using anti-HA (DDX3-HA). (C)
The core protein blocked interaction between the C-terminal fragment
of DDX3 and IPS-1. The C-terminal region of DDX3 (199–662 aa) called
DDX3 2-3c, IPS-1, HCV (O) and JFH1 or 1b core expression plasmids
were transfected into HEK293FT cells. After 24 hrs, cell lysates were
prepared and immunoprecipitation was carried out with anti-HA (DDX3
2–3c). Immunoprecipitates were analyzed by SDS-PAGE and Western
blotting with anti-HA or FLAG antibodies. The results are representative
of two independent experiments.
doi:10.1371/journal.pone.0014258.g005
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PLoS ONE | www.plosone.org 9 December 2010 | Volume 5 | Issue 12 | e14258(Fig. S2A). MDA5-dependent IFN-beta promoter activation was
also suppressed by the core expression (Fig. S2B). The inhibitory
effect of the core protein on DDX3-IPS-1 interaction was further
confirmed using an 1b core isoform isolated from a patient. This
HCV core protein also reduced interaction as well as IPS-1-
mediated IFN-beta promoter activation (Fig. 5A). The blocking
effect was relatively weak in cells expressing IPS-1 and full-length
DDX3 (Fig. 5B). We presume that this is because there are
multiple binding sites for IPS-1 in the DDX3 whole molecule [11].
For binding assay, we used DDX3 2-3c (across a.a. 199,662,
longer than 224,662) instead of the whole DDX3. In fact,
DDX3(199-662)-IPS-1 interaction was blocked by the additional
expression of core protein (HCVO, JFH1 or 1b core) in Fig. 5C.
Ultimately, HCV core protein suppresses IPS-1 signaling by
blocking the interaction between the C-terminal region of
DDX3 and the CARD-like region of IPS-1, and this inhibition
apparently causes the disruption of the active RIG-I/DDX3/
IPS-1 complex that efficiently induces IFN-beta production
signaling.
Localization of DDX3 and HCV core protein in O cells
We attempted to confirm this finding by tag-expressed proteins
and imaging analysis. In Huh7.5 cells IPS-1 colocalized with
DDX3 around the mitochondria (Fig. S3), and so did in the
hepatocyte lines Oc cells with no HCV replicon (Fig. 6A). In Oc
and Huh7.5.1 cells with no HCV replicon, abnormal distribution
of IPS-1 was barely observed (Fig. 6A, Fig. S3). In O cells
expressing DDX3 and IPS-1, by contrast, two distinct profiles of
IPS-1 were observed in addition to the Fig. 6A pattern of IPS-1:
diminution or spreading of the IPS-1 protein over mitochondria
(Fig. 6B,C). IPS-1 may be degraded by NS3/4A in some replicon-
expressing O cells as reported previously [5,28]. We counted
number of cells having the pattern represented by Fig. 6 panel B
and those similar to Fig. 6 panel C, and in most cases the latter
patterns were predominant.
What happens in the O cells with replicon when the core
protein is expressed was next tested. Using O and Oc cells, we
tested the localization of the core protein and DDX3 in
comparison with IFN-inducing properties (Fig. 3). In O cells with
full-length HCV replicon, DDX3 was localized proximal to the
lipid droplets (LD) (Fig. 7A top panel) around which HCV
particles assembled [29]. HCV core protein and DDX3 were
partly colocalized in the HCV replicon-expressing cells (Fig. 7A
center panel). The results were confirmed with HCV replicon-
expressing O cells where endogenous core and DDX3 were
stained (Fig. 7B upper panel). Partial merging between core and
DDX3 was reproduced in this case, too. In contrast, sO cells,
which possess a subgenomic replicon lacking the cording region of
the core protein, showed no merging profile of DDX3 and LD
(Fig. 7A bottom panel). Likewise, Oc cells barely formed assembly
consisting of LD (where the core assembles) and overexpressed
DDX3 (Fig. 7A bottom panel) or endogenous DDX3 (Fig. 7B
lower panel). O cells expressing DDX3 tended to form large spots
compared to Oc cells (with no replicon) and sO cells (core-less
replicon) with DDX3.
Overexpressed DDX3 allowed the Oc cells to induce IPS-1-
mediated IFN-beta promoter activation (Fig. 3B), while this failed
to happen in O cells having HCV replicon (Fig. 3A). Ultimately,
overexpressed IPS-1 did not facilitate efficient merging with
DDX3 in O cells with replicon (Fig. 6B,C) compared to Oc cells or
Huh7.5 cells with no replicon (Fig. 6A, Fig. S3). The results on the
functional and immnoprecipitation analyses, together with the
imaging profiles, infer that the IPS-1-enhancing function of DDX3
should be blocked by both NS3/4A-mediated IPS-1 degradation
and the HCV core which translocates DDX3 from the IPS-1
complex to the proximity of LD in HCV replicon-expressing cells.
Discussion
We investigated the effect of the HCV core protein on the
cytosolic DDX3 that forms a complex with IPS-1 to enhance the
RIG-I-mediated RNA-sensing pathway. We demonstrated that
the core protein removes DDX3 from the IFN-b-inducing
complex, leading to suppression of IFN-b induction. DDX3 is
functionally complex, since its protective role against viruses may
be modulated by the synthesis of viral proteins. DDX3 acts on
multiple steps in the IFN-inducing pathway [30]. In addition,
DDX3 interacts with the HCV core protein in HCV-infected cells
and promotes viral replication [16]. This alternative function is
accelerated by the HCV core protein, resulting in augmented
HCV propagation [14,16]. More recently, Patal et al., reported
that interaction of DDX3 with core protein is not critical for the
support of viral replication by DDX3, although DDX3 and core
protein colocalize with lipid droplet [15]. If this is the case, what
function is revealed by the interaction between DDX3 and HCV
core protein remain unsettled. At least, HCV replication is not
blocked by this molecular interaction [15].
It remains unclear in Fig. 4C why higher doses of JFH1 core
protein are required to inhibit enhancement of IPS-1 signaling by
endogenous DDX3 than by exogenously overexpressed DDX3.
One possibility is that endogenous DDX3 is preoccupied in a
molecular complex other than the IPS-1 pathway since DDX3 is
involved in almost every step of RNA metabolism and its
localization affects its functional profile [18,30].
Together with these findings, the results presented here suggest
that the HCV core inactivates IPS-1 in a mode different from
NS3/4A [5,31]. The core protein may switch DDX3 from an
antiviral mode to an HCV propagation mode. The core protein
localizes to the N-terminus of the HCV translation product, and is
generated in infected cells before NS3/4A proteolytically liberates
non-structural proteins and inactivates IPS-1. Our results on how
the HCV core protein interferes with the interaction between
DDX3 and IPS-1 add several possibilities to notions about the
HCV function on the IFN-beta-inducing pathway [18].
DDX3 appears to be a prime target for viral manipulation,
since at least three different viruses, including HCV [14], Hepatitis
B virus [32], and poxviruses [8], encode proteins that interact with
DDX3 and modulate its function. These viruses seem to co-opt
DDX3, and also require it for replication. The viruses are all
oncogenic, and may confer oncogenic properties to DDX3.
Figure 6. Distribution of DDX3 and IPS-1. (A) DDX3 colocalizes with IPS-1 on the mitochondria in Oc cells. HA-tagged DDX3 and FLAG-tagged
IPS-1 were co-transfected into Oc cells. After 24 hrs, cells were fixed with formaldehyde and stained with anti-HA polyclonal and FLAG monoclonal
Abs. Alexa488 (DDX3-HA) or Alexa633 antibody was used for second antibody. Mitochondria were stained with Mitotracker Red. Similar IPS-1-DDX3
merging profiles were observed in Huh7.5.1 cells (Fig. S3). (B,C) O cells with the HCV replicon poorly formed the DDX3-IPS-1 complex. Plasmids
carrying IPS-1 (100 ng) or DDX3 (150 or 300 ng) were transfected into O (HCV replicon +) as in Oc cells (no replicon, panel A). After 24 hrs, localization
of IPS-1 and DDX3 was examined by confocal microscopy. Two representatives which differ from the conventional profile (as in panel A) are shown.
Similar sets of experiments were performed four times to confirm the results.
doi:10.1371/journal.pone.0014258.g006
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PLoS ONE | www.plosone.org 10 December 2010 | Volume 5 | Issue 12 | e14258Figure 7. Partial association of endogenous and overexpressed DDX3 with HCV core protein in hepatocyte lines. (A) O cells with the
HCV replicon form DDX3-containing speckles in the cytoplasm. O cells contain full-length HCV replicon, and Oc cells do not [16]. O cells were
transfected with a plasmid expressing HA-tagged DDX3 (top panel). In other experiments, O cells were transfected with plasmids expressing HA-
tagged DDX3 and FLAG-tagged HCV core protein (center panel). After 24 hrs, cells were stained with anti-HA or FLAG antibodies. Proteins were
visualized with Alexa488 or 564 second antibodies and the LD was stained with BODIPY493/503. In the bottom panel, Oc cells (no replicon) and sO
cells with the core-less subgenomic replicon [16] were transfected with a plasmid expressing HA-tagged DDX3. After 24 hrs, cells were stained with
anti-HA antibodies. LD was stained with BODIPY493/503. (B) Endogenous DDX3-HCV core association in O cells. O or Oc cells were cultured to amplify
the HCV replicon. Cells were stained with anti-core mAb and anti-DDX3pAb and secondary antibodies. Similar sets of experiments were performed
three times to confirm the results.
doi:10.1371/journal.pone.0014258.g007
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translocation [33]. The DDX3 gene is conserved among
eukaryotes, and includes the budding yeast homolog, Ded1 [34].
The Ded1 helicase is essential for initiation of host mRNA
translation, and human DDX3 complements the lethality of Ded1
null yeast [14,35]. Another function of DDX3 is to bind viral RNA
to modulate RNA replication and translocation. Constitutive
expression of the HCV core or other DDX3-binding proteins may
impede IFN induction and promote cell cycle progression. These
reports are consistent with the implication of DDX3 in various
steps of RNA metabolism in cells that contain both host and viral
RNAs.
A continuing question is the physiological role of the molecular
complex of DDX3 and IPS-1 during replication of HCV in
hepatocytes. HCV proteins generated in host hepatocytes usually
induce an HCV-permissive state in patients, for example in the
IFN-inducing pathways. NS3/4A protease induces rapid degra-
dation of IPS-1 [5,31] and TICAM-1/TRIF [36]. NS5A interferes
with the MyD88 function [37]. Viral replication ultimately blocks
the STAT1-mediated IFN-amplification pathway [38]. PKR may
be an additional factor by which HCV controls type I IFN
production [39]. Our results add to our knowledge of the
mechanism of how HCV circumvents IFN induction in host cells:
HCV core protein suppresses the initial step of IFN-beta induction
by interfering with DDX3-IPS-1 association. Indeed, the core
protein functions as the earliest IFN suppressor, since it is
generated first in HCV-infected cells, and rapidly couples with
DDX3 to retract it from the IPS-1 complex, resulting in
localization of DDX3 near the LD (Fig. 7). It is HCV that hijacks
this protein for establishing infection. Although gene disruption of
DDX3 makes mice lethal, this issue will be further tested using
IPS-1 2/2 hepatocytes expressing human CD81 and occludin
[40], in which HCV replication would proceed.
DDX3 primarily is an accelerating factor for antiviral response
through IPS-1-binding. Many host proteins other than DDX3
may positively regulate HCV replication in hepatocytes in
association with the IPS-1 pathway. In this context, we know
LGP2 [41] and STING [42] act as positive regulators in virus
infection. Peroxisomes serve as signaling platforms for recruiting
IPS-1 with a different signalosome than mitochondria [43]. It
appears rational that HCV harbors strategies to circumvent these
positive regulators in the relevant steps of the IFN-inducing
pathway.
Imaging studies suggest that the complex of IPS-1 involving the
membrane of mitochondrial/peroxisomes differ from that free
from the membrane. Although IPS-1 is liberated from the
membrane by NS3/4A having largely intact cytosolic domain, it
loses the IFN-inducing function [5,31]. Our results could offer the
possibility that the clipped-out form of IPS-1 immediately fails to
form the conventional complex for IRF-3 activation any more [44]
or is easily degraded further to be inactive (Fig. 6C). Indeed, there
are a number of mitochondria-specific molecules which assemble
with IPS-1 [45]. Formation of the molecular complex on the
mitochondria rather than simple association between IPS-1 and
DDX3 may be critical for the DDX3 function.
Evidence is accumulating that HCV checks many steps in the
IFN-inducing pathway throughout the early and late infection
stages, and suppresses IFN production by multiple means.
Disruption of IPS-1 function by both NS3/4A and core protein
may be crucial in HCV-infected Huh7.5 cells, even though the
cells harbor dysfunctional RIG-I [46]. Type I IFN suppresses
tumors by causing expression of p53 and other tumor-suppressing
agents [47]. These unique features of the HCV core protein
require further confirmation, and should be minded in investiga-
tion of HCV persistency, chronic infection and progression to
cirrhosis and carcinoma.
Supporting Information
Figure S1 The IPS-1 complex. IPS-1 and HCV core bind C-
terminal regions of DDX3. DDX3 captures dsRNA at the C-
terminal domain. This figure is constructed from [11], [14] and
[16].
Found at: doi:10.1371/journal.pone.0014258.s001 (0.41 MB TIF)
Figure S2 DDX3 enhances RIG-I-mediated IFN-b promoter
activation induced by polyI:C. (A) DDX3 si-1 or control siRNA
was transfected into HEK293 cells with reporter plasmids and
RIG-I-expression plasmid or control plasmid (100 ng). After 48
hrs, cells were stimulated with polyI:C (20 mg/ml) with dextran for
4 hrs, and activation of the reporter p125luc was measured. (B)
MDA5 (25 ng), IPS-1 (100 ng), DDX3 (100 ng), JFH1 core
(50 ng) and/or p125 luc reporter (100 ng) plasmids were
transfected with HEK293 cells. Cell lysates were prepared after
24 hrs, and luciferase activities measured. The results are
representative of two independent experiments, each performed
in triplicate.
Found at: doi:10.1371/journal.pone.0014258.s002 (0.17 MB TIF)
Figure S3 DDX3 colocalizes with IPS-1 on the mitochondria in
Huh7.5.1 cells. HA-tagged DDX3 and FLAG-tagged IPS-1 were
co-transfected into Huh7.5.1 cells. After 24 hrs, cells were fixed
with formaldehyde and stained with anti-HA polyclonal and
FLAG monoclonal Abs. Alexa488 (DDX3-HA) or Alexa633
antibody was used for second antibody. Mitochondria were
stained with Mitotracker Red. A representative result from three
independent experiments is shown.
Found at: doi:10.1371/journal.pone.0014258.s003 (0.92 MB TIF)
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